WHO has approved the first malaria treatment specifically for infants, artemether-lumefantrine, ensuring safer dosing and improved outcomes. Previously, babies were treated with drugs meant for older children, increasing risks. With millions of cases and deaths annually, this breakthrough strengthens global efforts to reduce child mortality and brings hope for better malaria control worldwide.